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E-mail address: NBGusev@mail.ru (N.B. Gusev).Serine residues phosphorylated by protein kinase A (PKA) in the shortest isoform of human tau pro-
tein (s3) were sequentially replaced by alanine and interaction of phosphorylated s3 and its mutants
with 14-3-3 was investigated. Mutation S156A slightly decreased interaction of phosphorylated s3
with 14-3-3. Double mutations S156A/S267A and especially S156A/S235A, strongly inhibited interac-
tion of phosphorylated s3 with 14-3-3. Thus, two sites located in the Pro-rich region and in the
pseudo repeats of s3 are involved in phosphorylation-dependent interaction of s3 with 14-3-3.
The state of s3 phosphorylation affects the mode of 14-3-3 binding and by this means might modify
tau ﬁlament formation.
Structured summary:
MINT-7233358, MINT-7233372, MINT-7233384: 14-3-3 zeta (uniprotkb:P63104) and Tau 3 (uni-
protkb:P10636-3) bind (MI:0407) by molecular sieving (MI:0071)
MINT-7233323, MINT-7233334, MINT-7233346: Tau 3 (uniprotkb:P10636-3) and 14-3-3 zeta (uni-
protkb:P63104) bind (MI:0407) by crosslinking studies (MI:0030)
MINT-7233285, MINT-7233297, MINT-7233310: 14-3-3 zeta (uniprotkb:P63104) and Tau 3 (uni-
protkb:P10636-3) bind (MI:0407) by comigration in non-denaturing gel electrophoresis (MI:0404)
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The microtubule-associated tau protein is abundantly ex-
pressed in the axons of neurons and plays a crucial role in axonal
transport [1]. Six major isoforms of tau detected in the human
brain are generated by alternative splicing and contain from 352
(the shortest s3 isoform) to 441 (the largest s4 isoform) residues
[1,2]. These isoforms differ by the presence of either three (s3) or
four (s4) imperfect repeats forming microtubule-binding region
and by the presence of variable number of inserts in the N-terminal
half [1,2]. Tau belongs to the group of intrinsically disordered
proteins [3], however, short stretches located in the region of
imperfect repeats tend to form b-strands partially masked by
mobile N- and C-terminal tails [4]. Certain stimuli induce confor-
mational changes unmasking these b-strands [5] and leading to
formation of ﬁlaments and neuroﬁbrillar tangles. These aggregateschemical Societies. Published by E
in kinase B; s3, the shortest
d by protein kinase A; PMSF,
nolare hallmarks of Alzheimer’s disease and related taupathies [1,2].
Different factors affect transition of soluble tau monomers to
insoluble ﬁlaments and among them limited proteolysis, formation
of disulﬁde bonds and phosphorylation [1,2,5]. Tau contains more
than 20 sites phosphorylated by a number of different protein ki-
nases [6]. Phosphorylation of certain sites induces dissociation of
tau from microtubules, provokes phosphorylation of other sites
and/or partial proteolysis thus increasing the probability of aggre-
gation [2]. Therefore the fate of phosphorylated tau is of special
interest.
The recently published data indicate that tau interacts with
14-3-3 [6]. The family of 14-3-3 proteins is presented by seven
isoforms with especially high content in the brain [7]. These pro-
teins form homo- or heterodimers and predominantly interact
with proteins containing phosphorylated Ser (or Thr) in canonical
motifs [8]. Earlier published data indicate that 14-3-3 interacts
with the microtubule-binding site of s4 and this interaction is
independent of tau phosphorylation by cdc2-like protein kinase
[6]. It is supposed that serving as an adapter 14-3-3, stimulates
tau phosphorylation by a number of different protein kinases
[6,9–11]. 14-3-3 promotes aggregation of unphosphorylated tau
[11–13] and is presented in neuroﬁbrillar tangles in Alzheimer’slsevier B.V. All rights reserved.
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protein kinase A (PKA) or protein kinase B (PKB) increases the
interaction of tau with 14-3-3 and modiﬁes the effect of 14-3-3
on tau aggregation [12,13,16].
Until recently the role of different phosphorylation sites of tau
on its interaction with 14-3-3 was not analyzed in detail. This
paper deals with analysis of participation of certain sites phosphor-
ylated by PKA in the interaction of the shortest isoform of human
tau protein (s3) with 14-3-3.2. Materials and methods
2.1. Proteins
The cDNA corresponding to the human shortest tau isoform
containing 352 residues and denoted as s3 (Swiss-Prot ID
P10636-3) was PCR ampliﬁed and cloned as described earlier
[16]. Tau mutant S156A was obtained by the megaprimer method
using Pfu DNA polymerase (Sileks) and the following primer
TCCCGCACCCCGGCACTTCCAACCCCA. The double mutants S156A/
S235A and S156A/S267A were obtained using TCCAAGTGTGGC-
GCATTAGGCAAC (for S235A) and TCGAAGATTGGGGCACTGGA-
CAAT (for S267A) primers (mutagenic codons are underlined) and
cDNA encoding S156A tau mutant as a matrix. Resulting constructs
were veriﬁed by DNA sequencing and used for protein expression
and puriﬁcation [16]. Recombinant human 14-3-3f and the cata-
lytic subunit of mouse PKA were expressed and puriﬁed as de-
scribed earlier [16,17]. Protein concentration was determined
spectrophotometrically using e0.1% equal to 0.987 and 0.203 for
14-3-3f and tau, respectively.2.2. Protein phosphorylation
Tau or its mutants (5–15 lM) were phosphorylated at 37 C in a
buffer containing 20 mM Tris–HCl pH 7.5, 10 mM glycerol-1-phos-
phate, 1 mM MgCl2, 0.1 mM phenylmethane sulfonylﬂuoride
(PMSF), 15 mM b-mercaptoethanol (ME), 150–250 lM ATP and
trace amounts of [c-32P]ATP in the presence of catalytic subunit
of PKA. Kinetics and stoichiometry of phosphorylation were deter-
mined by incorporation of radioactive phosphate using a phospho-
cellulose-paper assay [16].2.3. Native gel electrophoresis
Fixed amounts of 14-3-3 were mixed with increasing quanti-
ties of tau or its mutants in buffer BB containing 20 mM Tris–
HCl pH 7.6, 150 mM NaCl, 5% glycerol, 0.1 mM PMSF and 15 mM
ME. The mixture was incubated for 40 min at 37 C and subjected
to native gel electrophoresis [18] with subsequent quantitative
densitometry. Under conditions used, the square under the peak
of 14-3-3 was proportional to the quantity of protein loaded on
the gel.
2.4. Chemical crosslinking
Isolated phosphorylated s3 or the mixture of 14-3-3 with
phosphorylated tau (or its mutants) were incubated in buffer
BB for 40 min at 37 C and glutaraldehyde was added up to
the ﬁnal concentration 0.045%. After 15 min incubation at 30 C
the reaction was stopped by addition of SDS-sample buffer.
The protein composition of the samples was determined by
SDS-electrophoresis on a 5–20% gradient polyacrylamide gel
[19]. The gels were stained by Coomassie R250 and subjected
to autoradiography.2.5. Size-exclusion chromatography
The samples (each 150 ll) of isolated 14-3-3, phosphorylated
tau or its mutants or mixtures containing 14-3-3 and phosphory-
lated tau species were preincubated for 30 min at 37 C and loaded
on a Superdex 200 (HR 10/30) column equilibrated with 20 mM
Tris–acetate pH 7.6, 150 mM NaCl, 5 mM MgCl2, 15 mM ME.3. Results
PKA transfers about 2 moles of phosphate per mole of s3 and
phosphorylates Ser156, 235, 267, 320 and 327 (corresponding to
Ser214, 324, 356, 409 and 416 of the longest s4 isoform) [20].
The rate and level of phosphorylation of these sites decreases in
the order S156 > S235 > S327P S320 > S267 for s3 isoform [21].
The primary structure at Ser156 (RTPpSLP) is close to the consen-
sus sequence (RXXpSXP) recognized by 14-3-3 [8] and it was
therefore postulated that this site might be responsible for s3-
14-3-3 interaction [12,16]. In order to check this suggestion we re-
placed Ser156, i.e. the main site of PKA phosphorylation, by Ala and
analyzed the effect of two other phosphorylation sites (Ser235 and
Ser267) on the interaction of phosphorylated s3 with 14-3-3. The
wild type s3 and its Ala mutants were subjected to phosphoryla-
tion up to 1.7–2.0 moles P/mole protein. Fixed amounts of 14-3-3
were mixed with increasing quantities of unphosphorylated (s3),
phosphorylated s3 (ps3) or its phosphorylated mutants and sub-
jected to native gel electrophoresis. Unphosphorylated s3 only
weakly interacts with 14-3-3 (Fig. 1) [16], whereas addition of
even small quantities of phosphorylated s3 was accompanied by
disappearance of the band corresponding to the isolated 14-3-3
and accumulation of a new band having lower electrophoretic
mobility, which presumably corresponds to the complex 14-3-3-
ps3 (Fig. 1A). Indeed, when this band was cut out, subjected to
the SDS-gel electrophoresis and silver-stained we detected two
protein bands corresponding to 14-3-3 and ps3 (Fig. 1B). Phos-
phorylated S156A mutant was less effective in 14-3-3 binding than
the wild type s3 and even at high concentrations of S156A signif-
icant portion of 14-3-3 remained free (Fig. 1). Thus, although phos-
phorylated Ser156 contributes to the tight binding of s3 to 14-3-3,
it is not unique for this interaction.
The double mutation S156A/S267A, further decreased interac-
tion of phosphorylated s3 with 14-3-3 (Fig. 1). The phosphorylated
double mutant S156A/S235A was very ineffective in 14-3-3 bind-
ing and its interaction with 14-3-3 was comparable with that of
unphosphorylated s3 (Fig. 1C). This indicates that phosphorylation
of Ser267 located in the fourth repeat and especially Ser235
located in the third repeat signiﬁcantly contributes to the binding
of s3 to 14-3-3.
Chemical crosslinking was utilized to conﬁrm these results. Two
bands were detected after crosslinking of isolated phosphorylated
s3 by glutaraldehyde, namely a strong radioactive band with Mr
46 kDa, corresponding to s3 monomer and a weak band with Mr
94 kDa corresponding to s3 dimer (Fig. 2A and B). Three main
bands were detected after crosslinking the wild type s3 with
14-3-3. The sharp band with Mr 28 kDa corresponds to the
14-3-3 monomer. The band with Mr 46 kDa corresponds to s3
monomer and the diffuse band with Mr 120–150 kDa corre-
sponds to the 14-3-3-s3 complex. The bands corresponding to
the 14-3-3-s3 complex had a higher Mr and were much more
intense than the band corresponding to s3 dimer (Fig. 2C and D).
The data obtained with the S156A mutant were qualitatively sim-
ilar to that obtained with the wild type s3. After crosslinking of
phosphorylated S156A/S235A or S156A/S267A mutants with
14-3-3 we detected four bands. In addition to the three above
mentioned bands we found a band with Mr 58 kDa corresponding
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Fig. 1. Interaction of unphosphorylated or phosphorylated wild type the shortest isoform of human tau protein (s3) and its phosphorylated mutants with 14-3-3 analyzed by
native gel electrophoresis. 14-3-3 at ﬁxed concentration 2.7 lM was mixed with increasing quantities of unphosphorylated tau (s3) or phosphorylated s3 (ps3) and
phosphorylated mutants (pS156A, pS156A/S235A and pS156A/S267A). Molar ratio s3/14-3-3 in the sample loaded on the gel is indicated above each lane. (A) Native gel
electrophoresis of the mixture of 14-3-3 and different species of s3. Isolated s3 and its mutants do not enter the gel. Positions of isolated 14-3-3 and 14-3-3-s3 complexes are
marked by arrows. (B) SDS-gel electrophoresis of the band corresponding to the 14-3-3-s3 complex (lane 1) and molecular mass markers (lane 2). (C) Dependence of 14-3-3
remaining free on the total concentration of unphosphorylated s3 (s3), phosphorylated s3 (ps3) or its phosphorylated mutants. The data presented are representative of three
independent experiments.
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S156A/S235A mutant indicating that the larger portion of 14-3-3
remained free. Moreover, in the case of the S156A/S235A mutant
the intensity and radioactivity of the band corresponding to the14-3-3-s3 complex was weaker than the corresponding bands in
the case of the wild type protein or two other mutants (Fig. 2).
Thus, phosphorylation of at least two sites (S156 and S235 or
S156 and S267) is important for tight interaction of 14-3-3 and s3.
2742 N.N. Sluchanko et al. / FEBS Letters 583 (2009) 2739–2742The method of size-exclusion chromatography was also used
for analyzing the interaction of 14-3-3 with phosphorylated s3
and its mutants. Isolated s3 (and its mutants) and isolated
14-3-3 are eluted as separate peaks with elution volumes 12.2
and 14.1 mL, respectively (Fig. 3). Formation of the complex 14-
3-3-ps3 is accompanied by an increase in the amplitude and
broadening of the peak eluted at 12.3–12.4 mL, which leads to a
signiﬁcant increase of the optical density at elution volume
13 mL (Fig. 3). Moreover, as we have shown earlier [16], the
fractions eluted between 12.5 and 13.5 mL contain both phosphor-
ylated s3 and 14-3-3. Increase of the amplitude at elution volume
13 mL was observed only in the case of complexes formed by
14-3-3 with phosphorylated wild type s3 and its S156A mutant,
but not in the case of double mutants of s3 (Fig. 3), thus indicating
that the double mutants only weakly interact with 14-3-3.
4. Discussion
Recently published data indicate that phosphorylation by PKA
enhances interaction of tau with 14-3-3 [12,13,16]. Sadik et al.
[12] assumed that this tight interaction is mediated by phosphor-
ylation of Ser214 of s4 (corresponding to Ser156 of s3). However
mutation S156A only weakly affected interaction of phosphory-
lated s3 with 14-3-3 (Figs. 1–3) thus indicating that this site is
not unique for 14-3-3 binding. Additional mutation S267A de-
creased interaction of S156A mutant with 14-3-3, and mutation
S235A induced even stronger inhibitory effect on the interaction
of phosphorylated s3 with 14-3-3. The pronounced effect of the
S235A mutation is probably due to the fact that the primary struc-
ture at Ser235 (KCGpSLG) is similar to the consensus sequence
(RXXpSX(P/G)) recognized by 14-3-3 [8]. Thus, phosphorylation
of at least two sites located in the Pro-rich domain (Ser156) and
in the microtubule-binding regions (Ser235 and/or Ser267) affects
interaction of s3 with 14-3-3. It is worthwhile to mention that the
earlier postulated phosphorylation-independent site of 14-3-3
binding is also located within the microtubule-binding region of
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Fig. 3. Size-exclusion chromatography of isolated phosphorylated s3 and its
mutants (12 lM per monomer, dashed lines), of isolated 14-3-3 (24 lM per
monomer, dash-dotted lines) or of the mixtures of 14-3-3 and s3 (or its mutants,
solid lines). The amplitude of 14-3-3 peak is much larger than that of s3 and it is not
shown.We suppose that the mode of 14-3-3 binding depends on the
location and quantity of phosphorylated sites in s3 structure. Weak
interaction of 14-3-3 with unphosphorylated (or weakly phosphor-
ylated) tau might promote formation of ﬁlaments as reported ear-
lier [12–14]. At the same time the highly speciﬁc and tight
interaction of 14-3-3 with phosphorylated tau results in formation
of stable complexes and might prevent conformational changes
leading to ﬁlament formation.Acknowledgement
The authors are grateful to A.A. Shemetov for his help in prep-
aration of tau mutants. This investigation was supported by the
Russian Foundation for Basic Research (Grant 07-04-00115).References
[1] Ballatore, C., Lee, V.M.-Y. and Trojanowski, J.Q. (2007) Tau-mediated
neurodegeneration in Alzeimer’s disease and related disorders. Nat. Rev.
Neurosci. 8, 663–672.
[2] Johnson, G.V.W. and Stoothoff, W.H. (2004) Tau phosphorylation in neuronal
cell function and dysfunction. J. Cell Sci. 117, 5721–5729.
[3] Mukrash, M.D., Bibow, S., Korukottu, J., Jeganathan, S., Biernat, J., Griesinger, C.,
Mandelkow, E. and Zweckstetter, M. (2009) Structural polymorphism of 441-
residue tau at single residue resolution. PLoS Biol. 7, e34.
[4] Andronesi, O.C., von Bergen, M., Biernat, J., Seidel, K., Griesinger, C.,
Mandelkow, E. and Baldus, M. (2008) Characterization of Alzheimer’s-like
paired helical ﬁlaments form the core domain of tau protein using solid-state
NMR spectroscopy. J. Am. Chem. Soc. 130, 5922–5928.
[5] Barghorn, S. and Mandelkow, E. (2002) Toward a uniﬁed scheme for the
aggregation of tau into Alzheimer paired helical ﬁlamens. Biochemistry 41,
14885–14896.
[6] Hashiguchi, M., Sobue, K. and Paudel, H.K. (2000) 14-3-3f is an effector of tau
protein phosphorylation. J. Biol. Chem. 275, 25247–25254.
[7] Aitken, A. (2006) 14-3-3 proteins: A historic overview. Semin. Cancer Biol. 16,
162–172.
[8] Rittinger, K., Budman, J., Xu, J., Volinia, S., Cantley, L.C., Smerdon, S.J., Gamblin,
S.J. and Yaffe, M.B. (1999) Structural analysis of 14-3-3 phosphopeptide
complexes identiﬁes a dual role for the nuclear export signal of 14-3-3 in
ligand binding. Mol. Cell 4, 153–166.
[9] Yuan, Z., Agarwal-Mawal, A. and Paudel, H.K. (2004) 14-3-3 binds to and
mediates phosphorylation of microtubule-associated tau protein by Ser9-
phosphorylated glycogen synthase kinase 3 in the brain. J. Biol. Chem. 279,
26105–26114.
[10] Chun, J., Kwon, T., Lee, E.J., Kim, C.H., Han, Y.S., Hong, S-K., Hyun, S. and Kang,
S.S. (2004) 14-3-3 protein mediates phosphorylation of microtubule-
associated protein tau by serum- and glucocorticoid-induced protein kinase
1. Mol. Cell 18, 360–368.
[11] Hernandez, F., Cuadros, R. and Avila, J. (2004) Zeta 14-3-3 protein favours the
formation of human tau ﬁbrillar polymers. Neurosci. Lett. 357, 143–146.
[12] Sadik, G., Tanaka, T., Kato, K., Yamamori, H., Nessa, B.N., Morihara, T. and
Takeda, M. (2009) Phosphorylation of tau at Ser214 mediates its interaction
with 14-3-3 protein: Implication for mechanism of tau aggregation. J.
Neurochem. 108, 33–43.
[13] Sadik, G., Tanaka, T., Kato, K., Yanagi, K., Kudo, T. and Takeda, M. (2009)
Differential interaction and aggregation of 3-repeat and 4-repeat tau isoforms
with 14-3-3f protein. Biochem. Biophys. Res. Commun. 283, 37–41.
[14] Layﬁeld, R., Fergusson, J., Aitken, A., Lowe, J., Landon, M. and Mayer, R.J. (1996)
Neuroﬁbrillary tangles of Alzheimer’s disease brains contain 14-3-3. Neurosci.
Let. 209, 57–60.
[15] Sugimori, K., Kobayashi, K., Kitamura, T., Sudo, S. and Koshino, Y. (2007) 14-3-
3 protein beta isoform is associated with 3-repeat tau neuroﬁbrillary tangles
in Alzheimer’s disease. Psychiat. Clin. Neurosci. 61, 159–167.
[16] Sluchanko, N.N., Seit-Nebi, A.S. and Gusev, N.B. (2009) Effect of
phosphorylation on interaction of human tau protein with 14-3-3f.
Biochem. Biophys. Res. Commun. 379, 990–994.
[17] Sluchanko, N.N., Chernik, I.S., Seit-Nebi, A.S., Pivovarova, A.V., Levitsky, D.I. and
Gusev, N.B. (2008) Effect of mutations mimicking phosphorylation on the
structure and properties of human 14-3-3. Arch. Biochem. Biophys. 477, 305–
312.
[18] Schaub, M.C. and Perry, S.V. (1969) The relaxing protein system of striated
muscle. Biochem. J. 115, 993–1004.
[19] Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of
the head of bacteriophage. Nature 227, 680–685.
[20] Scott, C.W., Spreen, R.C., Herman, J.L., Chow, F.P., Davison, M.D., Young, J. and
Caputo, C.B. (1993) Phosphorylation of recombinant tau by cAMP-dependent
protein kinase. J. Biol. Chem. 268, 1166–1173.
[21] Landrieu, I., Lacosse, L., Leroy, A., Wieruszeski, J-M., Trivelli, X., Sillen, A.,
Sibille, N., Schwalbe, H., Saxena, K., Langer, T. and Lippens, G. (2006) NMR
analysis of tau phosphorylation pattern. J. Am. Chem. Soc. 128, 3575–3583.
